Siga technologies (siga) shares tumble after mpox therapy fails, chief medical officer terminated - hagens berman

San francisco, oct. 23, 2024 (globe newswire) -- biopharmaceutical company siga technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, tpoxx®, to treat mpox.
SIGA Ratings Summary
SIGA Quant Ranking